> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection Extension for Outsourcing Facilities
- URL: https://www.fdaweb.com/info-collection-extension-for-outsourcing-facilities/
- Published: 2019-10-10T12:00:00.000Z
- Updated: 2026-09-15T01:55:44.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145214

*Federal Register* notice: FDA has submitted to OMB an information collection extension for “Electronic Drug Product Reporting for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act” (OMB Control Number 0910-0827). Outsourcing facilities are required to register with FDA and submit regular reports identifying the drugs compounded during the previous six-month period. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-10-10/pdf/2019-22189.pdf?ref=fdaweb.com).